Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Community Acquired Bacterial Pneumonia
Age: Adults
Dose: Intravenous – 150 mg
Frequency: every 12 hours
Duration: 5-7 days
Note: Indicated for treatment caused by susceptible microorganisms including Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible isolates), Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.
Indication: Community Acquired Bacterial Pneumonia
Age: Adults
Dose: Oral – 600 mg
Frequency: every 12 hours
Duration: 5-7 days
Note: Indicated for treatment caused by susceptible microorganisms including Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible isolates), Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: No approved pediatric dosage available
Note: Not recommended
Administration
  • Take as directed
  • Complete full course
Side Effect

Drug Interaction

Drug NameRisk Factors
No interactions listed
-

Disease Interaction

Disease NameRisk Factors
Hypersensitivity to Pleuromutilin Antibiotics
Risk of severe allergic reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.